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9Abstract
Bruton tyrosine kinase (Btk) belongs to the Tec family of non-receptor protein
tyrosine kinases. Mutations in the gene coding for Btk lead to a hereditary
immunodeficiency, X-linked agammaglobulinemia (XLA), in man. This family
of tyrosine kinases shares a common domain composition, with an N-terminal
Pleckstrin homology domain, the Tec homology (TH) domain, Src homology 3
(SH) and SH2 domain, and a C-terminal Src kinase domain. The TH domain
adjacent to the SH3 domain in Btk consists of two motifs, the Btk motif and
proline-rich regions (PRR) that conform to the canonical SH3 binding motifs.
This study aimed at elucidating the role of the N-terminal non-catalytic domains
(PH, TH, SH3 and SH2) in the regulation of the kinase activity of the Btk
protein, and exploring the nature of mutations in Btk encoding gene in Finnish
patients with XLA. Molecular modelling of Btk and its family members with
mutational analysis of Btk gave insights on the structural and molecular conse-
quences of amino acids alteration in the PH domain of the Btk. Using base
excision sequence scanning methodology followed by direct sequencing, sev-
eral families with XLA were studied. The role of the SH3 domain was studied
using circular dichroism (CD) and fluorescence spectroscopy by analysing binding
of peptides corresponding to segments of the PRRs, to the SH3 domain. The
N-terminal half of the PRR was shown to bind specifically, whereas the C-
terminal peptide had no detectable affinity. The TH domain had about four times
lower affinity for the SH3 domain (17.0 µM) than the N-terminal peptide (3.9
µM). For the PRR-SH3 domain, neither of the two peptides could compete for
the binding to the construct. However, the TH domain binding to the PRR-SH3
domain had two times lower affinity than to the SH3 domain alone. By using
intermolecular NMR cross-relaxation techniques combined with gel filtration
chromatography profiles, a dimer formation involving the PRR and the SH3
domain was identified. Further, using CD, fluorescence spectroscopy and tem-
perature gradient gel electrophoresis (TGGE), the unfolding process and stabil-
ity of the N-terminal (PH, TH, SH3 and SH2) domains of Btk was studied.
These results have helped us to gain insights into the function and regulation of
the Btk protein. Moreover, the involvement of the non-catalytic domains in
signalling and the concomitant disease phenotype upon amino acid alterations
is further elucidated.
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1 Introduction
1.1 Primary immunodeficiency disorders (PIDs)
Primary immunodeficiency disorders (PIDs) affect the functioning of the im-
mune system. They arise mainly due to mutations in genes, which are involved
in the production of the components of the immune system. Due to these intrin-
sic defects, affected patients are highly susceptible to persistent and recurrent
infections (Buckley et al., 1997; Smith and Notarangelo, 1997; Vihinen et al.,
2001). PIDs were first identified some 50 years ago (Smith and Notarangelo,
1997). In molecular terms, the gene whose defects cause the X-linked form of
chronic granulomatous disease (XCGD), was the first to be identified using
positional cloning technique (Royer-Pokora et al., 1986). X-linked agamma-
globulinemia (XLA) was the first reported human disorder in which a mutation
in the gene encoding a cytoplasmic protein tyrosine kinase was found (Tsukada
et al., 1993; Vetrie et al., 1993). Adenosine deaminase (ADA) deficiency was
the first primary immuno-deficiency in which gene therapy was attempted (Blaese
et al., 1995; Bordignon et al., 1995). Bovine enzyme replacement therapy has
usually been accompanied with polyethelene glycol (PEG), in the treatment of
patients with ADA deficiency, hence, the clinical impact of gene therapy has
been difficult to assess. Cavazzana-Calvo et al. (2000) reported the first suc-
cessful gene therapy trial for a patient with X-linked severe combined immuno-
deficiency.  A significant advancement over the pioneering studies of Bordignon
et al. (1995), using gene therapy in the treatment of ADA deficiency has also
been recently reported (Aiuti et al., 2002a; Aiuti et al., 2002b).
Most PIDs are characterized by an increased susceptibility of the individual to
opportunistic infections (Lederman and Winkelstein, 1985; Arkwright et al.,
2002). Patients with B-cell deficiency are liable to bacterial infections, whilst
patients with T-cell defects tend to be susceptible to various parasitic, viral and
fungal infections (Buckley et al., 1997; Vihinen et al., 2001). Diseases that af-
flict phagocytes cause mainly skin and oral bacterial infections and the forma-
tion of granulomas due to the spread of the causative bacteria to such organs as
the liver (Vihinen et al., 2001). In these patients fungal infections tends to cause
severe complications. Patients with certain PIDs are known to be susceptible to
some specific pathogens. Patients with X-linked lymphoproliferative syndrome
(XLP), a disease caused mainly due to mutation in the gene (SH2D1A) (Coffey
et al., 1998; Nichols et al., 1998; Sayos et al., 1998), are prone to Epstein-Barr
virus (EBV) infections. Whereas those with mutations in interleukin 12 (IL-
12), with the disrupted interferon-γ signaling, are susceptible to some forms of
idiopathic mycobacterial and Salmonella infections (de Jong et al., 1998).
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Some primary immune disorders are now known to result in autoimmunity. The
basis of such autoimmunity has been attributed to the inability of the host to
eradicate microbial pathogens and their antigens completely through the usual
immune pathways (Arkwright et al., 2002). Some specific examples of PIDs
that are associated with autoimmunity include those leading to phagocyte dis-
orders such as chronic granulomatous disease (CGD) or leukocyte adhesion
molecule deficiency (LAD), (for review see Arkwright et al., 2002). Mutations
in the apoptosis mediator genes TNFSF6, and TNFRS6 have also been shown
to lead to autoimmunity (Ochs et al., 1999). Some primary immune disorders
predispose to certain forms of cancer. Due to EBV infection in patients with the
X-linked Wiskott-Aldrich syndrome (WAS) the prevalence of EBV-driven lym-
phomas is high (Cotelingham et al., 1985).
Genes associated with PIDs are found on a number of chromosomes (Table
1.1).
TABLE 1.1 Some primary genetic disorders of the immune system
and their affected genes (adapted from Vihinen et al., 2000 with minor
changes)
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The majority of the genes code for multidomain proteins, although there are
some e.g. ADA and SH2DIA with a single domain (for details see Vihinen et
al., 2001 and references therein). Most of the protein defects implicated in PIDs
have been found to be involved in diverse cellular processes ranging from signal
transduction, transcription factors, phagocytosis, to cell surface receptors etc.
However, for many of these proteins, with their diverse locations, their exact
mechanisms of action have yet to be established.
1.1.1 X-linked agammaglobulinemia (XLA)
XLA is a disease resulting from defects in Btk protein. The disease is character-
ized by profound hypogammaglobulinemia, an early onset of bacterial infec-
tions, a decrease in the number of B-lymphocytes, and an almost complete lack
of plasma cells (Sideras and Smith, 1995; Smith and Notarangelo, 1997).  The
immunoglobulin levels in affected individuals are very low. The disease afflicts
about 1/200,000 males (Sideras and Smith, 1995; Ochs and Smith, 1996). The
associated infections, particularly bacterial meningitis and pneumonia, are often
life threatening and therefore, early diagnosis is critical for the management of
XLA (McKinney et al., 1987; Ochs and Smith, 1996).
Btk was identified as the molecular defect in XLA by two different approaches,
using positional cloning (Vetrie et al., 1993) and in a search for novel protein
kinases expressed in B lymphocytes (Tsukada et al., 1993). The gene was mapped
to the Xq21.3-22 region in the mid-portion of the long arm of the X-chromo-
some (Kwan et al., 1986; Ott  et al., 1986). The human gene encompasses 37.5
kb and is organized into 19 exons (Hagemann et al., 1994; Rohrer et al., 1994),
including a 5’ untranslated region (exon 1). Btk is a 659 amino acid long protein
in both man and mouse (Vetrie et al., 1993; Tsukada et al., 1993). It encodes a
cytoplasmic protein tyrosine kinase (PTK).
The study of XLA has profoundly contributed in the understanding of the im-
munological basics of the humoral immunity. Btk is expressed throughout the
development in B cells except the plasma cells (Sideras and Smith, 1995). In
XLA, the production of Btk is blocked at the transitional stage from pro-B to
pre-B cells resulting in B cell apoptosis (Anderson et al., 1996) (see Fig 1.1).
Moreover, as was recently shown in xid mice, the first manifestation of Btk
deficiency occurs in the transition from pro-B to pre-B stage (Cancro et al.,
2001). Thus, the initial effects of xid in mice and XLA in man are at the same
stage of B cell development (Cancro et al., 2001). Various types of XLA caus-
ing mutations have been identified in all Btk domains (Vihinen et al., 1999).
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The analysis of Btk expression in primary cells of XLA patients has shown that
majority of the individuals do not express the protein, regardless of the muta-
tion type (Gasper et al., 2000). So far, it has not been possible to predict how
specific mutations at critical sites in Btk affect the function and the concomitant
XLA phenotype (Gasper et al., 2000; Gasper et al., 1998). Further, correlation
between the protein expression level and differences in the clinical and immuno-
logical phenotypes have not been possible. Many individuals previously diag-
nosed as having common variable immunodeficiency or immunoglobulin sub-
class deficiency, have been shown to have Btk deficiency (Futatani et al., 1998;
Vórechvsky, 1994). The majority of the described mutations lead to a truncated
protein. Whilst the large majority of mutations are found in the coding region,
over 12% of mutations have been found to affect splice site recognition se-
quences (Vihinen et al., 1995a; Conley et al., 1998). Several XLA causing mu-
tations in Btk have been described and are collected in the BTKbase that is
available at http://www.uta.fi/imt/bioinfo/Btkbase (Vihinen et al., 1995a; Vihinen
et al., 1999). In addition to describing the mutations, the database also contains
clinical information regarding to patients.
Figure 1.1 The schematic illustration of B-cell development. Btk is ex-
pressed throughout B cell development, but down regulated in plasma
cells. Upon Btk mutation, there is a block in the development at the
transitional stage from pro- to pre- B cell leading to XLA in man and xid
in mice.
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2 Signal transduction
The term signal transduction implies the conversion of an input signal received
at the extracellular face of the plasma membrane into an intracellular signal that,
ultimately, leads to alteration of gene expression. The correct transmission of
the signal is vital for both unicellular and multicellular organisms; the stimula-
tion of cells from outside, due to signaling molecules, can trigger a cascade of
events leading to diverse cellular responses such as, differentiation, growth and
movement (Hunter, 1995). Various types of proteins, including transmembrane
receptors, G-protein subunits, adaptor proteins, kinases and phosphatases, are
involved in signaling.
The plasma membrane plays an important role as a meeting point for signaling
proteins. The association of signaling proteins with the membrane can be direct
or indirect (Mumby, 1997). The binding of a cytoplasmic protein to the mem-
brane could be achieved, for example, by modification of the proteins by lipid
(Mumby, 1997). Further, with specific protein-protein interactions, signals can
also be transduced through the membrane via an indirect mechanism. These
processes are regulated through covalent protein modification such as phos-
phorylation, one of the hallmarks of intracellular signaling (Carpenter and Cantley,
1996).
Btk protein is a non-receptor PTK known to be involved in B-cell survival, cell
cycle progression and proliferation in response to B cell receptor (BCR) stimu-
lation (Petro et al., 2000). The phosphorylation of a tyrosine residue in the
activation loop of Btk is essential for its participation in BCR signaling (Kurosaki,
1997).
2.1 Non-receptor protein tyrosine kinases
Approximately 20% of the ~32,000 human genes are known to encode proteins
that are involved in signaling (Blume-Jensen and Hunter, 2001). Among them
are, for instance the transmembrane receptors, adaptor proteins, kinases and
phosphatases. Included in the latter groups are the PTKs, a group of enzymes
that have evolved to play key roles in transmitting signals in multicellular organ-
isms. PTKs are found only in metazoans (Blume-Jensen and Hunter, 2001). In
the human genome, over 90 genes encode for PTKs and these can be divided
into two subgroups, receptor and non-receptor PTKs. Currently, there are 30
identified mammalian non-receptor tyrosine kinases which can be divided into
11 families based on amino acid sequence identities (Burkhardt and Bolen, 1996).
In addition to the kinase domain, PTKs have other conserved domains, which
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are also found in several distinct signaling pathways. These conserved domains
are thought to regulate signaling through their ability to mediate protein-pro-
tein interactions. These domains have consequently become the building blocks
for the formation of complex networks of interacting proteins (Saouaf, 1995).
Signaling domains are generally dynamic and plastic, and can be modified. They
mostly occur as part of domain assemblies in modular proteins. Although the
catalytic domain of most PTKs has low substrate specificity, the non-kinase
domains attached also interact with regulators and substrates in the context of
specific signaling processes and the cellular environment. Moreover, intra and
intermolecular interactions between domains can critically affect the kinase ac-
tivity of the enzyme.
The role of modular proteins in signaling has been a focal point in signal trans-
duction research over the last decade. Discoveries of proteins with variable
domains such as PH, SH3, SH2, SH1 or the kinase domain, PDZ, C1 and C2
(Hurley et al., 2002) and elucidation of their properties and functions, have
contributed greatly to the current understanding of signaling pathways. The
importance of the domain concept is reflected in the fact that each domain men-
tioned above occurs in a large number of different signaling proteins. Hence,
understanding the function of a particular domain in one protein can be used to
infer its function in many other proteins that contain the same domain. Thus,
domain information provides a simple and most powerful conceptual bridge in
attempts to understand the vast and complex sequence data from the human
genome (Hurley et al., 2002).
2.2 Tec family of cytoplasmic tyrosine kinases
The Tec family of PTKs is characterized by similar amino acid sequences (Fig.
2.1) and cells of the immune system express them predominantly. They have a
characteristc domain architecture comprising the N-terminal PH domain fol-
lowed by a Tec homology (TH) domain, which contains a Zn2+ binding Btk
motif and a proline-rich region, a SH3, SH2, and the C-terminal kinase domain.
Atypical member of the Tec family PTKs is Txk, which lacks the PH and part of
the TH domain. Moreover, the Drosophila type 1 splice variant of Btk29A, also
lack the PH domain. The structural similarity (Fig. 2.2) shared among the Tec
family members suggest that these proteins may have overlapping functions.
Tec family kinase homolog are also expressed in other species, such as Dro-
sophila melanogaster, skate and zebrafish (Roulier et al., 1998; Baba et al.,
1999; Haire et al., 1997; Haire et al., 1998). Btk29A, the Drosophila member
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of Tec kinases, exists in two different splice variants i.e. types 1 and 2 (Baba et
al., 1999). Type 2 of Btk29A is composed of 786 amino acids, hence it has the
highest molecular weight among Tec kinases (Baba et al., 1999). Detailed in-
formation relating to the Tec family protein tyrosine kinases is presented in the
Table 2.2
Table 2.2 Tec family PTKs
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Figure 2.1 Sequence alignments of Tec family members. Mutations caus-
ing XLA are indicated above the sequence, X indicating nonsense mu-
tations, # delections, and @ insertions.
2.2.1 The regulation of Btk
The Tec family proteins are involved in a vast array of signal transduction path-
ways many of which form communication networks. The role of these family
members in signaling has been best characterised for Btk in the context of BCR
signaling (for review see Smith et al., 2001). The family members are composed
of similar domains, which are the most commonly used domains involved in
signaling (see Fig. 2.2).
Figure 2.2 Domain organisations of Tec family protein tyrosine kinases.
Txk contains in the N-terminus unique cysteine rich region.
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The sequence similarity (Fig. 2.1) and expression patterns (in similar types of
cells) of the Tec family members suggest that this family is involved in potentially
overlapping pathways. The main pathways in which Btk has been implicated
includes those initiated by the B-cell antigen receptor (BCR), the high affinity
IgE receptor (Fc
ε
RI),  IL-5, G-protein coupled receptors (via association with
Gα12, Gqα or βγ subunits and the CD32), collagen or thrombin receptors in
platelets IL-3 (Deng et al., 1998; Sato et al., 1994; Kikuchi et al., 1995; Bence
et al., 1997;  Ma and Huang, 1998; Kawakami et al., 1994;  Queck et al., 1998).
Binding of an antigen ligand brings about the activation of BCR which, in turn,
activates Btk through a phosphorylation cascade (Park et al., 1996; Oda et al.,
2000). The stimulation of BCR is intimately linked to the activation of three
cytoplasmic tyrosine kinase families, i.e. the Tec family, Src family, and the Syk
family (Vihinen and Smith, 1996) (Fig. 2.3). Upon BCR cross-linking,
PtdIns(3,4,5)P3 is generated by phosphatidylinositol 3-kinase (PI3K) which then
leads to the PH domain-mediated translocation of Btk to the membrane (Li et
al., 1997). This binding to the lipid intermediate is followed by the phosphoryla-
tion of Y551, a highly conserved activation loop tyrosine, by a transient asso-
ciation with Lyn, a Src kinase (Fig. 2.3), causing a marked increase in Btk
activity. Subsequent autophosphylation of Y223 in the SH3 domain by the ki-
nase domain induces the full activation of Btk (Rawlings et al., 1996; Park et
al., 1996).
Recently it has been shown that antigen binding and oligomerization of the
BCR results in rapid translocation of BCR into lipid rafts (detergent insoluble
membrane microdomains enriched in cholesterol and sphingolipids) (Cheng et
al., 1999). Lyn kinase a member of the Src kinase family is concentrated within
the raft region. Thus lipid rafts can serve as platforms for signaling (Cheng et
al., 1999). The translocation of the BCR into lipid rafts has been shown to result
in the recruitment to BCR of several associated signaling components, such as
signal cascades, BLNK (B cell linker protein), PI3 kinase, VAv (a guanine nucle-
otide exchange factor) and Btk (Cheng et al., 2001) (Fig. 2.3).
Prior to the ligand stimulation Tec and Btk have both been observed to be
constitutively associated with gp130, the signal-transducing subunit for the IL-
6 cytokine (Matsuda et al., 1995). More recently, in the downstream of antigen
receptors in both B and T cells, Tec was shown to be activated (Yang et al.,
2001). As to the downstream effect of Btk, it is interesting that Btk has been
shown to be present in the nucleus of hematopoietic cells, although in a much
lower amount compared to the cytoplasm (Mohamed et al., 2000). Under cer-
tain experimental conditions e.g. due to the SH3 domain deletion, Btk has been
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localized to the nucleus and perhaps being involved in regulating gene expres-
sion (Mohamed et al., 2000). In fact, both Btk and Tec are known to modulate
transcription of cytokine genes in mast and T cells (Yamashita et al., 1998).
Evidence linking B cell receptor stimulation with Btk nuclear response was
recently found when Btk was shown to be involved in the activation of the
transcription factor NF-KB (Petro et al., 2000). Apart from these implied roles
in transcriptional activation and reprogramming gene expression in the nucleus,
Btk family kinases are also thought to have an effect on cytoskeletal reorgani-
zation and cell motility (Qui and Kung, 2000). In DT-40 cells lacking Btk, the
pattern of actin expression and its ability to aggregate was shown to differ from
the wild-type cells (Nore et al., 2000), suggesting that Btk is involved in
cytoskeletal reorganization.
Tec and Btk share common functions during B cell development (Ellmeier et
al., 2000). Itk and Txk co-exist in T cells (Schaeffer et al., 1999). The activity
of Tec/Btk is required for the proper generation of immature B cells. However,
Btk function seems to be more important than that of Tec as in Btk deficient
mice a reduction of pre-B cells was observed, but not in those lacking Tec
(Ellmeier et al., 2000). Btk has also been found to fully compensate for the loss
of Tec, but Tec is not able to fully compensate for the loss of Btk in mice cells
(Ellmeier et al., 2000). Itk, on the other hand, has been shown to associate
directly with CD28, a T-cell costimulatory molecule (August et al., 1997). Fur-
ther, Tec like Itk is activated downstream of CD28, upon the phosphorylation
of Dok (a molecule that interacts with the GTPase activating protein of Ras and
Ras-GAP) (Yang et al., 1999). Moreover, upon reconstitution of Btk deficient
DT40 cells Itk and Tec have been shown to have an analogous function to Btk
in at least PLC-γ2 signaling (Tomlinson et al., 1999).
Btk has earlier been implicated in a regulatory role in tyrosine phosphorylation
of PLC-γ2 and subsequent calcium mobilization in BCR mediated signaling
(Fluckiger et al., 1998) (see Fig. 2.3). In this cascade, the SH2 domain-contain-
ing inositol-polyphosphate 5’-phosphate (SHIP) (Fig. 2.3) has been implicated
as an on/off switcher of Btk catalytic activity (Nore et al., 2000). In chicken
DT40 cells the patterns of tyrosine phosphorylation in wild type and Btk defi-
cient cells were found to be similar (Takata and Kurosaki, 1996). Syk (spleen
tyrosine kinase) family kinase as shown in Fig. 2.3, is involved in Akt activation,
and it has been shown to act as an upstream regulator of BCR induced PI3-
kinase, with Btk regulating the BCR-mediated Akt activation downstream of
PI3-kinase. Akt is known to be a target of PI-3K (Chan et al., 1999). Further,
the activation of other Tec family members e.g. Itk upon Src/CD28-induced
activation in response to interleukin-6 stimulation has been found to also re-
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quire PI3-kinase activity (Lu et al., 1998). The evidence that null Btk and xid
mice are similar to p85a null mice further supports the concept that Btk and
PI3-kinase are within the same pathway(s). Both mice were found with reduced
numbers of mature peripheral B cells and diminished proliferative response to
anti-IgM, anti-CD40, and liposaccharide (Fruman et al., 1999).
Figure 2.3 Schematic representations of the signaling pathways regu-
lating Btk.
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Tec family signaling generally involves the control of complex survival and dif-
ferentiation events (Smith, et al, 2001). The phenotype of a Btk deletion mutant
could exhibit a similar pattern with its pronounced differentiation block. How-
ever, under differential experimental conditions this kinase has the ability to
protect against (Solvason et al., 1998), or induce apoptosis (Islam, et al, 2000;
Uckun et al., 1996 ). Further, a constitutively active mutant form of Btk pro-
motes tumorigenesis in cell lines (Li  et al., 1995), whilst, in transgenic mice, the
constitutive expression of the same mutant results in abnormalities of the lym-
phoid organs with arrest in B lymphocyte development (Dingjan et al., 1998).
Bmx induces apoptosis in myeloid progenitor cells in the presence of G-CSF
(Ekman et al., 2000) and the combined deficiency of Itk and Txk leads to a
decrease in the sensitivity of CD-3 mediated apoptosis (Schaeffer et al., 1999).
When put together, these observations seem to imply that the cell phenotype
plays a key role on whether Tec kinases will induce cell survival or promote
apoptosis (Islam and Smith, 2000).
The Src family members Blk, Fyn, Lck, and Lyn are present in B cells, where
they are involved in signal transduction induced by binding of an antigen ligand
to the BCR (Reth and Wienands, 1997). They interact via their SH2 domain
with Syk, and also bind to other signaling molecules. Activation of the Src
family kinases and Syk are the key events in the early steps of BCR signaling
(Fig. 2.3). It is known that Syk phosphorylates tyrosine residues in the ITAM
(immunoreceptor tyrosine based activation motif) motifs in BCR (Flaswinkel
and Reth, 1994), and hence sets into motion the activation of PTK signaling
cascades (Flaswinkel and Reth, 1994). The two SH2 domains of Syk are likely
to be involved in the binding to the double tyrosine-phosphorylated ITAMs of
the BCR (Fig. 2.3.). The deletion of the gene coding for Syk in a chicken cell
line clearly implicates Syk in the signaling pathways between BCR and phos-
pholipase Cγ (Craxton  et al., 1999). Src family kinases are also involved in the
phosphorylation of Btk (Mahajan et al., 1995).
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3 Btk non-catalytic domains
As discussed above, the Tec family kinases are predominantly expressed in cells
of the immune system. The expression patterns demonstrate their ability to play
diverse regulatory roles in various physiological processes. Table 3.1 summa-
rizes some of the molecules known to interact with the non-catalytic domains.
Apart from the subtle sequence differences, it is most likely that the versatile
nature of the constituent domains and their various binding partners are what
permits the Tec family kinases to participate in such diverse actions. Below, the
Btk non-catalytic domains are discussed in more detail.
Table 3  A summary of some of the molecules known to interact with
the N-terminal domains of Tec family cytoplasmic protein tyrosine
kinases. Some binding partners have only been shown to interact with
specific Tec kinases, and this is indicated in parentheses.
3.1 PH domain
The PH domains consisting of about 120 residues are highly divergent, and
have been found in a number of signaling and cytoskeletal proteins including
protein tyrosine and serine/threonine kinases and their substrates, phospholi-
pase C, GTPase activating proteins, guanine nucleotide releasing factors, and
adaptor proteins (Shaw, 1996). Although the precise function of the PH domain
is not fully understood, several lines of evidence suggest a critical role in Btk
function. In many cases, it has been found to act as a membrane localization
domain (Fukuda et al., 1996; Hyvönen and Saraste, 1997).
The structure for several PH domains including Btk has been determined
(Hyvönen and Saraste, 1997). Despite very low sequence identity, the struc-
tures have the same fold consisting of a ß-barrel formed of two ß-sheets and a
C-terminal α-helix that caps one end of the ß-barrel. PH domains are highly
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polar (Blomberg and Nilges, 1997). The structure of the Btk PH domain re-
veals R28 to be one of the most highly conserved residues in this motif. Several
charged residues including R28 and E41 form a cleft near the N-terminus of the
domain. These residues are directly involved in the ligand binding (Baraldi et
al., 1999). The inositol compound binds between loops ß1-ß2 and ß3-ß4 where
both the R28 and E41 are located (Baraldi et al., 1999). The binding of E41K
mutant was studied in a cocrystal with Ins(1,3,4,5)P4 (Baraldi et al., 1999). In
another study, R28C substitution was found to have reduced binding to
Ins(1,2,3,4)P4, presumably because the substitution removes the basic arginine
from the ligand-binding cleft and this affects the strength of the electrostatic
polarization (Fukuda et al., 1996).
Residues implicated in the binding of the PH domain to phosphoinositide com-
pounds have been localized in Btk, pleckstrin, and PLC δ1 (Baraldi et al., 1999;
Harlan  et al., 1995; Ferguson et al., 1995). The positively charged surface of
the PH domain binds to the negatively charged phosphate groups of the
phosphoinositol molecules (Baraldi et al., 1999). Several XLA-causing muta-
tions including the Xid mutant R28C are located within the PH domain (Vihinen
et al., 1998; Vihinen et al., 1999, de Weers et al., 1994). The knockout variant
of R28C in mice exhibited a much milder phenotype (Thomas et al., 1993; Kerner
et al., 1995). In humans, patients with missense mutation of the corresponding
residue (R28) as in xid have a severe B cell deficit and classical XLA (de Weers
et al., 1994).
By using a retroviral passage mutagenesis scheme, a gain of function mutant
(E41K) of Btk, located in the PH domain, was isolated (Li et al., 1995). The
mutant allows the constitutive expression of Btk due to its increased affinity for
phosphoinositol compounds.  The expression of this mutant was shown to drive
the growth of NIH3T3 cells (Li et al., 1995). It was found to enhance transpho-
sphorylation of Y551 by endogenous Src family tyrosine kinases, and
autophosphorylation at position Y223 within the SH3 domain. The combined
phosphorylation(s) and autophosphorylation(s) lead to constitutive membrane
association via binding by phosphoinositol products of PI3K, e.g PI(3,4,5)P3
and 1,3,4,5-tetrakisphosphate resulting in the activation of Btk (Rawlings et al.,
1996; Baraldi et al., 1999). The interaction between the PH domain and PIP3 is
presently the best-characterized requirement for membrane targeting of the pro-
tein. Btk PH domain has also been found to interact with proteins, including F-
actin and focal adhesion kinase (FAK), suggesting multiple mechanisms for regu-
lating Tec kinases (Qiu and Kung, 2000; Lewis et al., 2001). Further, the carboxy
terminus of the PH domain has been shown to modulate binding to the βγ sub-
unit of heterotrimeric G proteins and, in conjunction with the Btk motif, to
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facilitates the interaction of Btk with the Gα12 subunit of heterotrimeric G
proteins (Tsukada et al., 1994;  Jiang et al., 1998).
3.2 TH domain
The TH domain in Btk consists of two motifs, the Btk motif and the proline rich
region (PRR) (Vihinen et al., 1994a; Vihinen et al., 1997). The complete TH
domain can be found only in the Tec protein family. The Btk motif follows the
PH domain in several forms of Ras GTPase-activating protein 1 and also in a
putative interferon γ-binding protein (Vihinen et al., 1995b). The function of the
TH domain is not fully understood, although SH3 domains bind to PRR in vitro
and the Btk motif seems to be essential for interactions with G proteins (Clapham
and Neer, 1997).
The Btk motif consists of a highly conserved stretch of amino acids found in
Tec kinases, Ras GAP, and IGBP (Vihinen et al., 1997). It structure has been
determined in a cocrystal with the PH domain (Hyvönen and Saraste, 1997;
Baraldi et al., 1999). The motif has a novel fold with a coordinated Zn2+ ion
binding which packs against the ß-sheet of the PH domain. This motif seems to
be crucial for the function of Tec family PH domains (Hyvönen and Saraste,
1997). A finding that in Txk, which is devoid of the PH domain, the Btk motif
is also missing also supports functional linkage.
Btk contains a duplicated sequence of proline rich stretches at the C-terminal
portion of the TH domain. In other Tec family kinases (except for Bmx), a
homologous stretch is also found. Bmx contains a canonical SH3 domain-bind-
ing PXXP motif, however, the surrounding residues do not conform to the
SH3-binding fingerprint. The proline rich region in the TH domain of Itk was
shown to make an intramolecular contact with the SH3 domain (Andreotti et
al., 1997). The two PRRs in the TH domain of Btk interact with the SH3 do-
mains of Fyn, Lyn and Hck (Yang et al., 1995). Site-directed mutagenesis of the
proline residues in the PRRs of Btk abolishes the interaction with SH3 domains
(Yang et al., 1995).
3.3 SH3 domain
The SH3 domain consists of approximately 60 amino acids. They are present in
a wide variety of proteins ranging from cytoskeletal proteins, such as myosin 1
and the α-chain of spectrin, to signal transduction proteins, e.g non-receptor
tyrosine kinases and phospholipase C. Recent data from the genome sequenc-
ing projects further suggest that 63 proteins in Drosophila, 55 in Caenorhabditis
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elegans, and 25 in Saccharomyces cerevisiae contain at least one form of this
domain (Rubin et al., 2000). SH3 domains bind to proline rich peptides and
proteins. Both biochemical and genetic evidence have demonstrated that SH3
domain-mediated interactions are necessary for proper signaling by e.g. recep-
tor tyrosine kinases (Pawson, 1995). The solution structure of the Btk SH3
domain has been determined using nuclear magnetic resonance (NMR) spec-
troscopy (Hansson et al., 1998). The structure of the Btk SH3 domain consists
of two tightly packed anti-parallel β-sheets that form a sandwich-like fold.
The structural basis for the interactions between the proline-rich peptide ligands
and SH3 domains are well understood (Lim et al., 1994). Based on the mode of
binding, two classes of ligands (class 1 and 2) have been defined, distinguished
by the orientation of the bound ligand (Mayer and Eck, 1995). Ligands of both
classes contain a PXXP core sequence that anchors the ligand to the receptor,
in the polyproline type II (PPII) helical conformation. The core sequence of the
ligand, provides the promiscuity of binding to different SH3 domains, the flank-
ing residues are unique to individual SH3 domains and bind to specific pockets
(Lim et al., 1994). These findings combined with successive phage display ex-
periments have provided a framework for an algorithm to predict specific bind-
ing sites for any SH3 domain from its primary sequence (Brannetti et al., 2000).
In the Btk SH3 domain the potential ligand-binding site is formed of residues
Y223-Y225, D232, W251, P265, and Y268 (Hansson et al., 1998).
Recent studies show that SH3 domains, under certain circumstances bind ligands,
which lack the PxxP core binding motifs. For example, the peroxisome Pix-
SH3 domain in Pak, the sequence that recognizes the SH3 was found to be
PPPVIAPRPETKS (Manser et al., 1998). On the other hand, PxxDY provides
the site for the binding of the SH3 domain of the epidermal growth factor re-
ceptor substrate Eps8 (Mongiovi et al., 1999). The SH3-domain of the immune
receptor adaptor molecule SKAP55, recognizes a novel tyrosine based
RKxxYxxY motif (Kang et al., 2000). Further, in YAP VPMRLR is the minimal
sequence requirement for YAP recognition by the SH3 domain of p53 protein
(Gorina and Pavletich, 1996). Conversely, as many SH3 ligands containing the
PxxP core motifs have been detected by direct filter binding and yeast two
hybrid systems, it is safe to assume that for most SH3 domains the PxxP core
motif is the target recognition sequence. The recent comparison of the yeast
SH3 domains with several other SH3 domains showed the SH3 domains, which
recognize canonical PxxP motifs, to be the most numerous (Cesareni et al.,
2002).
In Itk, a intramolecular regulatory association has been identified between the
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PRR and the adjacent SH3 domain (Andreotti et al., 1997). More recently, by
using 2D-NOESY in combination with HSQC spectra measurements, an inter-
molecular interaction between the SH3 and SH2 domains of Itk was found
(Brazin et al., 2000). The interaction provides an insight on the possible mecha-
nism for displacement of the intramolecular interaction between the PRR and
SH3 domain (Brazin et al., 2000; Ogawa et al, 2002).  Possibly, the intermo-
lecular interaction releases the SH3 domain-binding site that could be blocked
by the intramolecular interaction, a step that may be necessary for the full acti-
vation of the Tec family members. A point mutation in the Itk SH3 domain,
W208K, completely abrogates the intermolecular interaction and, also elimi-
nates self-association of Itk (Brazin et al., 2000). Similarly, by introducing two
additional lysines i.e. N383K, A384K (present in the Btk SH2 domain), using
C-terminal rational modification of Btk SH3-SH2 protein, combined with C337
substitution (C337S and C377M) in the surface of the SH2 domain, the solubil-
ity and homogeneity of the Btk SH3-SH2 construct was improved (Nera et al.,
2000). The addition of lysines at the N- or C-terminus has previously been
shown to increase protein solubility (Ingley and Hemmings, 1999). The engi-
neering of the Btk SH3-SH2 domains benefited from the observations gathered
from the Btk SH2 model structure (Vihinen et al., 1994b). The dimer formation
observed between Btk SH3-SH2 proteins could be intramolecular due to disul-
fide bridge formation, rather than intermolecular, since mutations C377S and
C377M within the SH2 domain abrogate dimerization (Nera et al., 2000). The
SH3-SH2 dimerization requires in addition to proper sequence, complementarity
in structure and also complementarity outside the actual recognition site (Vihinen
and Smith, 1998). Obviously, it will be essential to carry out further analysis on
Btk SH3-SH2 to study the nature of this interaction.
A critical event in the catalytic activation of Btk is transphosphorylation of
Y551 by Src in the catalytic domain. This is followed by autophosphorylation
of Y223 in the SH3 domain. The observed self-association described above that
involves the proline rich region open up the possibility that the
autophosphorylation of Y223 could occur in either trans or in cis. The substitu-
tion Y223F in the Btk SH3 domain results in enhanced fibroblast transforma-
tion (Park et al., 1996), suggesting that the SH3 domain has a negative regula-
tory role (Park et al., 1996). The scenario of trans or cis activation does have
implications for the understanding of the activation of Btk and other Tec family
proteins. Thus, targeted mutants changing some of the residues within this do-
main and the adjacent TH domain would be vital to reveal the important residue(s)
that are critical for either trans or cis activation. However, as recently shown
(Hansson et al., 2001), changing the critical prolines in both the N-terminal
PRR (Btk residue P189 and P192) and the C-terminal PRR (P203 and P206),
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that are thought to be critical in making van der Waals contact in the binding
pockets, do not completely abrogate intermolecular interactions. This implies
that other residues distal from these might contribute to the SH3 domain inter-
actions.
3.4 SH2 DOMAIN
SH2 domains contain about 100 amino acids. They play a central role in a num-
ber of cellular processes, including growth, immune response, metabolism, mi-
togenesis, motility and gene transcription (Kuriyan and Cowburn, 1997). SH2
domain-containing proteins take part in the coordination of signal transduction
pathways by binding to phosphotyrosine molecules. Binding specificities of sev-
eral SH2 domains have been determined by using phoshotyrosine (pY) peptide
libraries and phage display (Songyang et al., 1994; Cochrane et al., 2000). Most
of the XLA-causing mutations in Btk SH2 domain disrupt the pY peptide bind-
ing sites (Vihinen et al., 1994; Vihinen and Smith, 1996; Vihinen et al., 1995).
The three-dimensional structures of several SH2 domains have been determined
(e.g. Waksman et al., 1992; Waksman et al., 1993; Xu et al., 1995; Eck et al.,
1993). The conserved fold contains a large central antiparallel α-sheet and an
associated smaller α-sheet, flanked by α-helices on each side. The pY-contain-
ing ligand binds to the SH2 domain in an extended conformation. The crystal
structures of  SH2 domains in complex with high-affinity peptides have shown
that several residues are involved in the phosphotyrosyl peptide binding. The
number of residues binding, in addition to pY, varies from three to six or seven.
Regions outside the actual pY binding region can be essential for affinity and
specificity (Vihinen and Smith, 1998). The most important conserved interac-
tion between the SH2 domain and its ligand is the direct interaction between the
pY phosphate group and the guanidinium group of an arginine (R307 in Btk).
Other important residues for pY binding in Btk are R288 and S309. Residues
forming a second ligand-binding pocket for the residue pY+3 are found in αA,
βB, βD, and the loop connecting strands B and C. These residues provide the
specificity for pY+1 and pY+3 affinity (Kuriyan and Cowburn, 1997).
 The Btk SH2 domain contains a single cysteine residue, C337. According to
the model of SH2 domain, C337 is situated at the surface of the domain (Vihinen
et al., 1994). In Grb2, oxidation and subsequent dimer formation impair protein
crystallization (Cochrane et al., 2000). Using mutagenesis to replace the Btk
C337 with Ser or Met, dimer formation was prevented (Mattsson et al., 2000).
The C337S or C337M substitutions do not impair phosphotyrosine binding nor
do they affect the secondary structure of the Btk SH2 domain (Mattsson et al.,
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2000).
A recently identified B-cell linker protein (BLNK or SLP-65) as one of the
major Btk SH2 binding proteins explains the role of Btk SH2 domain in calcium
signaling (Hashimoto et al., 1999; Su et al., 1999). Upon BLNK phosphoryla-
tion by Syk (Spleen tyrosine kinase), BLNK is thought to provide docking sites
for Btk SH2 domain as well as for PLC-γ2. Thus, this provides a scenario where,
Btk and PLC-γ2 are brought into close proximity (Hashimoto et al., 1999;
Kurosaki and Tsukuda, 2000). When Btk is activated via the mechanisms ear-
lier discussed (see also Fig. 2.3) it phosphorylates PLC-γ2 leading to its full
activation (Kurosaki and Tsukuda, 2000). In this process, phosphorylated BLNK
was found to be vital further implying that BLNK is the direct connector be-
tween Btk and PLC-γ2. However, the effect of Btk on PLC-γ2 was abrogated
when a mutant variant of Btk SH2 domain was used in a heterologous transfec-
tion system (Hashimoto et al., 1999).
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4 Prelude to Experimental approaches: Spectroscopic methods
in brief
CD Spectroscopy: Circular dichroism (CD) spectroscopy is a powerful tool for
the studies of biochemical systems in solution. CD is sensitive for the shape of a
protein molecule. The principles of CD spectroscopy are based on the chirality
of a protein backbone and the side chains (For a complete details see Fasman,
(1996)). This method can provide information about the secondary and tertiary
structure of a protein molecule.
Fluorescence spectroscopy: Fluorescence spectroscopy can reveal information
about the intrinsic environment of a biological molecule. The method is a sensi-
tive mode to view the structural and dynamic characteristics of macromolecules
(for details see Gore (2000)). Fluorescence measurements are based on the
ability of a molecule to absorb electromagnetic radiation. Upon the absorption
via a quantum mechanical process, the molecule is transformed from a ground
state to an excited state. The absorption of light results in an electronic transi-
tion in the molecule. Through a process that is determined from the Beer-Lam-
bert law, the electron is transformed from the highest occupied molecular or-
bital (HOMO) to the lowest unoccupied molecular orbital (LUMO).
The fluorescence properties of proteins are highly individual; hence, it has long
been viewed as a sort of fingerprint of the individual protein. The aromatic
amino acids, phenylalanine, tyrosine, and tryptophan absorb light in the ultra-
violet spectral range. Among these, Y with molar absorptivity of 270= 1405 m-
1
 cm-1 and W 280 = 5579 m-1 cm-1 has been used extensively.
Using the intrinsic fluorescence properties of tryptophan, an indole amino acid,
with excitation wavelength at 280 nm and emission at 345 nm, we studied the
affinity of the two-proline rich regions within the TH domain for the Btk SH3
domain. With this approach, the dissociation constant of the reactions was cal-
culated from the Michaelis-Menten equation.
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5 Aims of the study
Bruton tyrosine kinase plays a crucial role in B cell development. Both genetic
and biochemical methods have been used to illustrate the physiological impor-
tance of Btk in B cell signaling. This has been clearly demonstrated with the
finding that mutations in the genes encoding Btk lead to immunodeficiency in
both man (XLA) and mice (xid).
The present study focuses on the role of the non-catalytic PH, TH, SH3 and
SH2 domains in the cooperative regulation of the activity and interactions of
the full-length protein.
The detailed aims of the study were:
1) to extend the knowledge relating to the structural dynamics of Btk.
2) to study the role of the SH3 domain in intra/intermolecular inter  ac-
tions of Btk.
3) to elucidate the nature of the Btk mutation(s) in Finnish patients with
XLA.
4) to analyze the thermal/chemical stability and the unfolding process of
the non-catalytic PH, TH, SH3 and SH2 domains.
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6 Experimental approaches
6.1 Mutation scanning using base excision sequence scan-
ning (BESS) method (I and III)
The upstream primer for each exon (1-19) was radioactively labelled as de-
scribed [I and III]. Samples were incubated at 37°C for 30 minutes, and then
inactivated by heating at 70°C for 5 minutes. Each of the nineteen BTK exons
was amplified using the improved primers as described by Vorechovský et al.
(1995). The PCR reactions were carried out as described in ref. I & III.
The amplified products were excised using BESS excision enzyme reaction
(Epicentre Technologies, USA), and subjected to 8% polyacrylamide sequenc-
ing gel electrophoresis. Exons revealing differences after scanning with G- and
T-tracker were reamplified without radiolabel. The PCR products were resolved
in a 1% agarose gel stained with ethidium bromide. The band of interest was
excised and purified using QIAquick PCR purification kit (Qiagen, Germany).
DNA sequencing was carried out for both strands using an automated ABI
PRISMTM 310 Genetic Analyser (PE Applied Biosystems), with the same prim-
ers as used in the PCR reactions. Detected mutations were confirmed by com-
parison of the resulting sequence with the reported coding sequence (Vetrie et
al., 1993).
6.2 Molecular cloning and expression (II, IV and V)
 cDNAs encoding the desired domains were amplified using polymerase chain
reaction (PCR). Cleavage sites for selected endonucleases were included in the
designed primers. The amplified PCR fragments were digested and cloned into
a vector with a poly-histidine (His)-tag for the TH domain and glutathione-S-
transferase (GST)-fusions for the SH3, PRR-SH3 and PH-SH2 domains, re-
spectively. The PH-SH2 constructs were cloned into a pBAT vector (Peränen
et al., 1996). The authenticity of all constructs was verified by DNA sequenc-
ing. Cloning was carried out in Escherichia coli DH5a strain.
The different domains were expressed in E. coli strain BL21 (DE3) or BL21/
pUBS20 strain for the PH-SH2 construct. The domains were expressed by fer-
menting the cells in 2xTY medium containing 2% glucose as a catabolic repres-
sor at 37°C, or 30°C for the TH domain. Expression was induced with isopro-
pyl-D-thiogalactopyranoside (IPTG) when absorbance at 600 nm reached 1.8
nm. Induction was carried out for 4 hours with the exception of the PH-SH2
construct, which had 20 hours induction. The harvested cells were lysed using
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Bead beater cell breaker.
6.3 Protein purification using chromatography
(II, IV and V)
The cDNAs encoding the recombinant proteins were cloned to GST/His-tag
fusion vectors except for the PH-SH2 construct. The over-expressed proteins
in the supernantant were first purified using an affinity column containing GSH-
Sepharose or Ni2+-NTA-agarose respectively. The bound fusion products were
digested overnight with thrombin (for GST fusion) at room temperature, and
the proteins eluted with PBS (phosphate buffer saline) buffer. After the affinity
purification, the proteins were further purified by gel-filteration on a Superdex
75 column. Then, SDS polyacrylamide gel electrophoresis and N-terminal amino
acid sequencing were used to confirm the identity of the purified proteins. For
further studies, the proteins were concentrated using membrane filters with a
10 kDa cut-off. The protein concentrations were determined as described in
(II).
6.4 Molecular modeling/sequence analysis (I and III)
Molecular modeling was carried out essentially as described in reference I. Briefly,
the computer assisted modeling of the Tec family PH domain was done by uti-
lizing the 3D structure of the Btk PH domain (Hyvönen and Saraste, 1997) as a
template. The models were generated using InsightII. Upon searching loops
from the database that contained a representative selection of the PDB files,
deletions and insertions were modeled. Sequence analysis was carried out using
programs such as gap as contained in the GCG sequence analysis package
(Devereux et al., 1984). ClustalW (Higgins et al., 1994) was used for multiple
sequence alignment analysis.
6.5 Biophysical studies of molecular interactions
6.5.1 CD spectroscopy  (II and V)
The CD measurements were made on a Jasco J-720 instrument. The measure-
ments were performed as described in ref II & V respectively. CD spectra are
often reported in terms of molar ellipticity. In the work presented in this thesis,
the ellipticity data were converted to molar ellipticity (θ) (in units of deg cm2
dmol-1) using the equation:
{θ}= {θ}
obs(MRW)/10lc,
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where {θ} is ellipticity, {θ}obs is the observed ellipticity in degrees. MRW is
the mean residue weight of the protein, c is the concentration of the protein in
mgml-1, and L is the optical pathlength of the measuring cell in centimeters.
The unfolding transition of the protein (PH-SH2) domains was acquired by
recording the CD signal at 222 nm from 25 to 70oC, with a scanning slope of
65oC/hour, 0.5 nm bandwidth and 0.1 cm cuvette.
6.5.2 Determination of dissociation constant (Kd) (II
and V)
A simple binding association scheme was assumed for the reaction. The binding
of the SH3 domain to either the peptide or the TH domain was assumed to be
reversible and to form a complex such that SH3 + P  SH3–P. The fluores-
cence changes (∆F) were directly related to the fraction of SH3–P or protein
complex formed.
The differences in fluorescence due to ligand binding were analysed using the
plot of A/V against A with the equation:
A  = Km  + 1 
. A
V       V      V
where A is the concentration, V is the fluorescence change due to ligand bind-
ing and KM is the Michaelis constant. This plot has been shown to be more
accurate than the double reciprocal plot.
6.5.3 NMR Spectroscopy (IV)
NMR measurements were carried out using Varian Inova 500, Bruker DRX
500 and DRX 600 spectrometers equipped with 5 mm triple-resonance 1H/
15N/13C probes respectively. The measurements were performed as described
in (IV).
6.5.4 Temperature gradient gel electrophoresis (V)
The temperature gradient gel electrophoresis (TGGE) was performed on a
Biometra TGGE system. 8% polyacylamide gels with 0-4 M concentration of
urea were cast on a polybond film as recommended by the manufacturer
(Biometra, Göttingen, Germany). The gel was placed on the horizontal gradi-
ent block and connected to the electrode tanks using pre-soaked electrode wicks.
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The temperature gradient was set from 28 to 65°C. The sample was loaded
onto the polyacrylamide gel attached to the polybond film, and the sample sub-
jected to a pre-run electrophoresis for 10 minutes at room temperature enabling
the sample to migrate onto the gel. The system was disconnected, the empty
slot of the gel rinsed with the running buffer, and the polyacrylamide gel cov-
ered with a pre-cut film. The electrode wicks were placed on top of the cover
film and the sandwich covered with an acryl-glide treated cover glass plate.
After completion of the electrophoresis, the gel was stained using silver stain-
ing method.
36
7 Results
7.1 Mutations XLA causing in the non -catalytic domains
of Btk  (I and III)
Btk contains the PH, TH, SH3, SH2, and the kinase domains. Mutations in the
genes encoding the Btk domains lead to XLA in man. Several XLA-causing
mutations in genes encoding the above mentioned domains in Btk have been
described (Vihinen et al., 1999; Vihinen et al., 2001). Using BESS method com-
bined with direct sequencing, we studied the prevalence of mutations in patients
with XLA disease. We identified XLA causing mutations in seven families out
of eight. In seven unrelated families we observed distinct mutations of which six
were novel. Carrier detection was performed in four families. Four of the seven
mutations affected the kinase domain gene region, three were found in PH and
one in SH2 domain (Table 7.1). There was a high proportion of insertions in the
investigated patients. There were a frameshift causing insertions in six patients,
four were in introns, one in the upstream noncoding region and one in exon 18
leading to a frameshift mutation and the consequent truncation of the protein.
In addition to the disease-related mutations a previously described silent poly-
morphism, C/T (Bradley et al., 1994; Rodriguez et al., 2001), at the 2031 cDNA
position was identified. The clinical profiles of all the patients showed classical
XLA. Some of the patients showed a positive family history of the disease, but
in one case the mutation was found to be new.
Table 7.1
Table 7.1 BTK mutations in XLA patients and carriers
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7.2 Structural interpretations of XLA causing mutations
in the gene encoding Btk PH domain region and compari-
son with the Tec family PH domains (I)
Pleckstrin homology domains are known to be involved in different interactions
including binding to inositol compounds, protein kinase C isoforms, and
heterotrimeric G proteins. Most Tec family PTKs contains a PH domain. The
sequence alignment of the Tec family PH domains and the modeling of the three
dimensional structure of the domains enabled us to compare their similarity and
gene mutation pattern. The majority of the disease-causing changes in Btk PH
domain are located in the inositol-binding region. Many of the alterations within
this region either reduce or reverse the electrostatics of the domain. In the four
Tec family members that we compared, similar fold and electrostatic properties
were observed but the binding regions were dissimilar.
Many PH domain alterations have been shown to alter the binding of the PH
domain to IP4 because of the removal of a positive charge from the binding
pocket. IP4 interacts with Btk via residues in β1-3 and in the loop between β1
and β2 of PH (Baraldi et al., 1999). The minimal PKC binding region (Yao et
al., 1997) contains residues R28 and Y39 of this region. Thus, this region con-
tains essential amino acids that impair Btk function when altered.
The IP4 molecule was docked to the domain models according to the binding
site in Btk. Using the structural models we interpreted the effects of the muta-
tions. It was found that the substitutions K12R and S14F most likely prevented
binding to IP4 due to the introduction of a bulky side chain into the binding
pocket. The alterations T33P, V113D, S115F, T117P all were found to caused
a sterical clash with the ligand. L19 is in the immediate proximity to the ligand-
binding pocket and Y39 is a ligand-binding residue. Thus, the alterations L19E,
Y40C or Y40R disturb the electrostatic properties of the domain, and hence
reduce binding.
7.3 TH/SH3 domain partners in the downstream regula-
tion of Btk interaction (II and IV)
Enzymatic activities of protein kinases are regulated by various intra- and inter-
molecular interactions. By applying biophysical techniques we investigated the
role(s) of SH3 domain binding sequences present in the TH region of Btk.
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7.3.1 interactions of Btk TH and SH3 domains (II)
The PRR sequence/motif of the TH domain in Tec family proteins can interact
with several SH3 domains (Yang et al., 1995). Tec PTKs have the SH3 domain
adjacent to the TH domain. We analysed the binding of the SH3 domain of Btk
to the proline rich segments by using synthetic peptides. Peptides correspond-
ing to the two Btk PRR repeats, peptide 1 TKKPLPPTPE (Btk residues 184-
193) and peptide 2 LKKPLPPEPA (residues 198-207), were synthesized. CD
and fluorescence scanning spectroscopy showed, that the Btk SH3 domain in-
teracts specifically with the N-terminal proline rich region. Similar interaction
has been previously reported for the Itk (Andreotti et al., 1997). The CD spec-
tra of both peptides were measured and both had a negative extrema at about
202 nm. Competition assays with the peptides was used to test the interaction in
the PRR-SH3 construct. The CD spectra of the Btk SH3 domain (amino acids
212-275) and the N-terminally extended version (amino acids 178-275) be-
tween 190 and 250 nm were measured. The sums of the CD spectra of Btk SH3
domain, peptide 1, as compared to the mixture of the two, indicated that the
combined spectrum does not obey simple additive rules. The TH domain in
competition with the Btk SH3 domain was used to further characterize the
interaction.
The binding affinity of the interaction between the TH and SH3 domains of Btk
was determined by using fluorescence scanning spectroscopy. The affinities
measured for peptide 1 binding to the SH3 domain, TH domain binding to the
SH3 domain, the TH domain binding to the extended PRR-SH3, and peptide 1
binding to the PH-SH2, were found to be 3.9 µM, 17.0 µM, 36.2 µM, and 350
µM respectively. Peptide 2 did not show binding even when used in high con-
centrations. These results indicate that interaction between the TH and SH3
domain contribute to the function and regulation of the Tec family PTKs.
7.3.2 Intermolecular interactions involving the TH
domain (IV)
The dimer equilibrum of the PRR and the SH3 domain was studied using gel
permeation chromatography, intermolecular NMR cross-relaxation measure-
ments, and [15N]-NMR relaxation measurement. We showed monomer-dimer
equilibrium of the Btk PRR-SH3 with a Kd of 60 µM. The gel chromatography
profiles showed the Btk PRR-SH3 domain retention to be concentration de-
pendent. The titration of a synthetic peptide corresponding to peptide 1 onto a
[15N] labelled sample and monitored using an NMR spectrum supported a
monomer-dimer equilibrum in the PRR-SH3 that is concentration dependent.
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7.4 Stability and unfolding of the Btk non-catalytic domains
(V)
CD spectroscopy and temperature gradient gel electrophoresis (TGGE) were
used to analyse the stability and unfolding of the PH, TH, SH3 and SH2 do-
mains. The CD spectrum of the protein showed intense negative minimas at 208
and 222 nm, with a positive peak close to 195 nm.
The temperature-induced denaturation using TGGE for the multidomain pro-
tein gave a single Tm of 45°C. The result indicates that a single unfolding initia-
tion process leads to the coordinated denaturation of the four domains. The
ellipticity at 222 nm as a function of temperature was followed to understand
the corporate dependance of the different domains. The thermal transition curves
indicate that at high temperatures, the molar ellipticity is not zero: (θ)222 = -
10,10 mdeg at 75°C. This implies the presence of some residual secondary struc-
ture even at high temperatures as previously reported (Venyaminov and Yang,
1996).
Based on the CD measurements we calculated a number of parameters. The
thermodynamic parameters defined include the Tg;  which is the upper tem-
perature at which ∆G0 (T) is zero; ∆Hg, which is the enthalpy of denaturation
at Tg; and ∆Cp, the change of heat capacity upon protein unfolding. We calcu-
lated the transition point of the enthalpy of denaturation (Tg) of the PH-SH2
protein and the van’t Hoff enthalpy upon denaturation to be 322K and Hm 323
kcal/mol, respectively. Further, with the use of the van’t Hoff analysis, the ∆Cp
was calculated to be 16.5  ± 1.9 kJmol-1K-1. These parameters were analysed
with the assumption that the denaturation process follows a two state N  D
transition. Previously, it has been shown that small proteins, like the SH3 do-
main usually unfold in a two state transition (Knapp et al, 1996; Viguera et al
1994; Fersht, 1999). Thus far, only the stability and peptide binding specificity
of the Btk SH2 and SH3 domain has been reported (Tzeng et al., 2000; Knapp
et al., 1998).
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8 DISCUSSION
8.1 XLA causing mutations
Single stranded conformational polymorphism (SSCP) followed by direct se-
quencing has this far been widely used for molecular diagnosis of XLA and
several other immunodeficiencies. In our study, base excision sequence scan-
ning (BESS) method (Hawkins and Hoffman, 1997) coupled with direct se-
quencing was used for the mutation analysis in BTK gene. By using this ap-
proach, we studied eight unrelated families. The XLA causing mutations iden-
tified in our study were located in the PH, SH2 and the kinase domain (see
Table 7.1). From the families we studied, different mutations were found: two
insertions, two inframe insertions, an unknown mutation in the intron 14 lead-
ing to amino acid change in the tyrosine kinase domain, and a two base substi-
tution in the intron 4. All the patients showed XLA phenotype. All the disease-
causing mutations are novel. The silent polymorphism C/T at 2031 in one pa-
tient had previously been described (Bradley et al., 1994; Rodriguez et al.,
2001). Previous work has described, XLA-causing mutations in all the Btk do-
mains encoding gene and are collected in the BTKbase (Vihinen et al., 1999;
Vihinen et al., 2001).
Most of the mutations available in the database are located in the PH, SH2 and
the kinase domain and only few has thus far been seen in the TH and the SH3
domain. Indeed, it is not clear if a missense mutation in the PRR-region of the
TH domain could cause the disease. A substitution has been found in this re-
gion, E205D, but this patient also had another mutation leading to truncation in
the PH domain (Vórechovský et al., 1995). Another known mutation replaces
T184 (in the beginning of the first PRR) with a proline. However, in this case
there is again a frameshift mutation truncating a major part of the protein
(Vórechovsky et al., 1997). Although, a large number of XLA-causing gene
mutations have been identified, so far no causative missense mutations in the
gene encoding the SH3 domain region have been found.
8.2 Intra/intermolecular interaction(s): a mode for Tec
family kinase regulation
Inter and intramolecular interactions play an important role in the regulation of
many PTKs. Studies have shown that the PRR of Btk interacts with the SH3
domains of Src family kinases i.e. Fyn, Lyn, and Hck (Cheng et al., 1994). In Itk
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the PRR was shown to interact in an intramolecular fashion  with the SH3
domain (Andreotti et al., 1997). We were interested to study the nature of this
interaction(s) in Btk. With different spectroscopic techniques we were able to
bring into focus the interaction pattern(s) of the TH and the SH3 domains.
Since both the tested proteins and peptides were optically active, it was possi-
ble to determine binding affinities. To accurately determine equilibrium con-
stants for binding of ligands to SH3 domain fluorescence measurements were
used (Otto-Bruc et al., 1993., Cussac et al., 1994,  Vidal et al., 1999). With this
method, the affinity for the interaction between the peptides, TH and the SH3
domains were determined. We also used NMR spectroscopy, which is particu-
larly useful in the study of protein structure and dynamics in solutions. When a
protein structure is known, NMR can be used to study interactions between the
protein and ligands. Usually, this is achieved by observing the perturbation of
the protein chemical shifts upon isotope labeling. In our case, this method was
used to study the intermolecular interactions between the TH and the SH3 do-
mains. Both [15N]-HSQC and NOESY-HSQC experiments were carried out,
combined with gel chromatography profiles. The results showed a monomer-
dimer equilibrum involving the PRR suggesting that interaction between the
TH and SH3 domain contribute to the function and regulation of the Tec family
kinases.
The affinity of the PRR and the SH3 domain in Tec has been studied (Pursglove
et al., 2002). The N-terminal PRR (KTLPPAP), residues 155-161 in Tec, and
the C-terminal PRR (KRRPPPPIPP) residues 165-174, were independently ti-
trated into 15N-labeled Tec SH3 domain. The changes in the chemical shifts of
resonances in the HSQC spectrum were measured as a function of ligand con-
centration. The interaction surface on the SH3 domain was defined and the
binding affinity estimated. For the intramolecular interaction of Tec SH3 do-
main with the N-terminal PRR the Kd was found to be between 1.7-2.0 µM
(Pursglove et al., 2002).
For the Tec SH3 domain, an intermolecular interaction involving the PRR has
also been reported by applying surface plasmon resonance (Pursglove et al.,
2002). The wild-type PRR-SH3 protein was found to bind to the SH3 domain
with a Kd of 68 µM (Pursglove et al., 2002). This is consistent with our meas-
urements for Btk (Kd 60 µM). In Tec, the disruption of the N-terminal PRR by
mutagenesis had no significant effect on the affinity, whereas the alteration of
the C-terminal PRR had a marked effect (Kd 2.2 mM) on the ability to bind the
SH3 domain surfac indicating that this region is critical for the intermolecular
interaction (Pursglove et al., 2002). Thus, in Tec the C-terminal PRR is respon-
sible for the interaction while in Btk the N-terminal PRR is essential (Fig. 8.2).
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Our results clearly indicate that the N-terminal PRR of Btk interacts with the
SH3 domain. The lack of spectral shift in the PRR - SH3-peptide complex
suggests that Tec family members might share a similar mode of internal regu-
lation by binding of the TH domain to the SH3 domain. Dimer formation of
these domains could prevent the binding of low affinity ligands. Recently, the C-
terminal PRR in Btk was shown to play a more robust role in dimer formation
as compared to the N-terminal PRR (Laederach et al., 2002) (Fig.8.2 C).  Al-
though, the N-terminal PRR competed for dimer formation, it had a remarkably
weaker affinity (Laederach et al., 2002). Three conformational states for dimer
formation have been proposed to coexist at equilibrium (Hansson et al., 2001),
i.e.
1) the N-terminal PRR binds across the dimer interface,
2) one of the N-terminal PRRs binds the other monomer while the other is
uncomplexed, or
3) both PRRs bind across the dimer interface
Thus, the formation of a dimer could prevent intramolecular interactions, which
are important for regulation of the protein.
The SH3 domain in the PSD-95 (post-synaptic density protein 95 kDa) of the
MAGUKS (membrane-associated guanylate kinases) family has been shown to
have the ability to adopt different modes in its interaction and regulation (McGee
et al., 2001). In PSD-95 the SH3 domain interaction with the GK fragment
differs from the other SH3 domains so that the interaction occurs via 3D do-
main swapping involving the C-terminal portion of the SH3. 3D domain swap-
ping involves the exchange of complementary structures by proteins to gener-
ate dimers or higher order oligomers (Newcomer, 2001). Previous studies of
protein systems that undergo swapping have indicated that the hinge or linker
region between two interacting domains plays an important role in determining
the preference for intra/intermolecular interaction (Newcomer, 2001; 2002;
Schlunnegger et al., 1997). It would be interesting to ascertain if this also hap-
pens in the Btk TH/SH3 interaction.
To further elucidate this interaction in Tec family members, the three-dimen-
sional structure of the full-length protein is essential. However, dimerization
behavior has been observed for the Btk PH domain (Baraldi et al., 1999). These
findings indicate that self-association plays a central role in the regulation of the
Btk/Tec family protein tyrosine kinases.
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Figure 8.2 Schematic representations of the Btk PRR interactions. (A)
The N-terminal PRR interacts with the SH3 domain-binding site in an
intramolecular fashion. (B) Mutation of the C-terminal PRR does not
show any significant effect on the interaction. (C) Proposed dimeriza-
tion mode of the protein. (D) The interconvertion of the dimer in a
symmetry mode.
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8.3 The biological implications of Btk SH3 domain inter-
actions
Our results show that the Btk SH3 domain plays a number of regulatory roles,
these include inter and intramolecular regulation. Obviously the interaction of
this domain with other domains within Btk is important for the overall function
of Btk. Most of the PTKs exhibit similar patterns of regulation. Two different
microarray chips were used to monitor gene expression patterns in a cell line
with non-functional Btk. Btk itself was induced with Src kinases (Islam et al.,
2002) implying similar regulation pattern for these proteins.
The interaction(s) of the Btk TH and SH3 domains, as shown by the results
presented in this study, suggests a mechanism by which the accessibility of the
TH and SH3 domains regulates the kinase activity of Btk. Recently, the deletion
of the PRR sequence in Itk (Hao and August, 2002) was shown to result in a
50% reduction of basal activity of this protein, further implying that this region
is essential for the regulation of Tec family kinases. The modulation of the SH3
domain by Y223 autophosphorylation has been predicted to block binding to
the domain (Park et al., 1996; Rawlings, 1999; Yang et al., 2000). Exogenous
partners that may disrupt the intra/intermolecular interactions between the TH
and SH3 domains can potentially participate in the regulation of the Btk family
members.
One of the roles suggested for the Btk TH and SH3 domain interactions is to
regulate and suppress the kinase activity (Ma and Huang, 1998; Yang et al.,
2000). The Src family kinases are known to interact with Btk TH domain via
their SH3 domain (Ma and Huang, 1998). Tec family kinases have been shown
to recruit other proteins, for example Src and Syk kinases, that uncouple initi-
ated signaling via their SH3 domain (Mano, 1999). Another regulator of Btk
interactions is Sab, an SH3-domain binding protein that preferentially associ-
ates with Btk by binding the Btk SH3 domain via its PxxP motif (Yamadori et
al., 1999). The interaction between Sab and Btk SH3 domain results in the
inhibition of Btk activity with a dramatic reduction in both early and late BCR-
mediated events including calcium mobilization, IP3 production, and pro-
grammed cell death (Yamadori et al., 1999). Such interactions with proteins
that have the ability to regulate the phosphorylation state of the full-length pro-
tein gives insight on the mechanism required to sustain enzyme de-/activation
via the interaction between the TH and the SH3 domains.
Btk is homologous to Src in the region spanning the SH3, SH2, and the kinase
domain. Although it does not possess the canonical C-terminal phosphorylation
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site present in the Src family kinases, it does share a similar hydrophobic bind-
ing pocket responsible for ligand interaction (Williams et al., 1998; Vihinen and
Smith, 1998). The crystal structure of the peptide encompassing the SH3-SH2
domains of Lck (a Src family member), showed that the domains dimerize (Eck
et al., 1994). In Fyn, site directed mutagenesis studies demonstrated that the
dimerization was phosphorylation independent. Mutations of the Fyn pY bind-
ing residue (R176K) did not prevent dimerization (Panchamoorthy et al., 1994).
Furthermore, mutations of S186P and R190C, in the SH2 domain of Fyn, did
not affect recognition of pY (Panchamoorthy et al., 1994). In Fyn, it seems that
alterations in the phosphate-binding region do not affect SH2-SH3 domain dimer-
ization. For most protein tyrosine kinases the binding of the SH2 domain to the
pY residue (in order to repress the kinase activity) requires the SH3 domain
(Williams et al, 1998; Vihinen and Smith 1998; Xu et al., 1997; Sicheri and
Kuriyan, 1997; Panchamoorthy et al., 1994; Erpel et al., 1995). Previously it
has been shown that the substitution K186R in Btk increases binding to Fyn
(Yang et al., 1995). Using mutagenesis, P189 was found to be the most crucial
residue for binding to Btk SH3 domains (Yang et al., 1995; Patel et al., 1997),
notably the substitution of the neighbouring P187 alanine did not cause any
significant change.
In c-Src kinase the regulation of the kinase domain by phosphorylation of the
C-terminal tail was found to require both the SH3 and SH2 domains as eluci-
dated by a coexpression experiment of Src mutants and Csk in yeast (Superti-
Furga et al., 1993; Okada et al., 1994). The main intramolecular contacts that
stabilize the inactive conformation of Src are those of the SH2-kinase linker
with the SH3 domain, and the linker between SH2 and the N-terminal kinase
lobe (Sicheri and Kuriyan, 1997). These interactions hold the enzyme in an
inactive state due to limited conformational freedom (William, et al., 1998). An
accessible ligand binding surface and RT (arginine and threonine) loop are es-
sential for the function of SH3 domains (Superti-Furga et al., 1993; Okada et
al., 1994; Erpel et al., 1995; Barila and Superti-Furga., 1998 ).
Recent data (Lowry et al., 2001) suggest that down-regulated Btk has a higher
basal activity than down-regulated c-Src, possibly due to different structural
conformations of the active sites and activation loops. The finding that the Btk
catalytic domain cannot autophosphorylate at Y551 in the absence of the SH3/
SH2 or the PH/TH modules, whilst the c-Src can autophosporylate at its equiva-
lent site Y416 (Lowry et al., 2001), implies that the Btk catalytic domain relies
on these domains to recognize the substrate or to modulate substrate accessibil-
ity. In this respect, further work is required to fully comprehend the role(s) of
the TH/SH3 interaction(s) on the one hand, and the interaction between the
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SH3 and SH2 domains on the other hand.
8.4 The dynamics of the Btk N-terminal domains
We studied the unfolding and the stability of the Btk N-terminal domains. Ther-
mal and chemical induced denaturation was followed at 222 nm using CD spec-
troscopy and TGGE. The reverse of the unfolding experiment was not done as
it has previously been reported that the refolding process of multidomain pro-
teins in vitro occur at a lower rate due to the slown correct pairing of the folded
units (Jaenicke, 1987). When applying CD spectroscopy to protein denatura-
tion and unfolding studies, it is assumed that the changes observed occur due to
the sensitivity of the system to the changes in the environment. And also due to
the changes of chromophoric amino acids resulting from temperature perturba-
tion and the resultant local conformational changes in the full-length protein.
These observations are supported by e.g. an earlier study on myosin (Holtzer
and Holtzer, 1992), where the effect of temperature on the protein was attrib-
uted to the local changes in the helical content.
Local interactions at the secondary structure level and interactions between
domains and subunits are thought to contribute to the net free energy of protein
stabilization (Jaenicke, 2000). Understanding the individuality of the different
Btk domains in concert with stability studies would profoundly increase the
understanding of the biological functions of the full-length protein. In recent
times, studies of protein folding, unfolding and in particular of misfolding have
been implicated in a number of so called conformational diseases i.e. transmis-
sible spongiform encephalopathies and Alzheimer’s disease (Ellis and Pinheiro,
2002) thus providing a wider relevance for such studies.
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9 Future perspectives and conclusions
The three dimensional structure of Btk is vital to study the functional mecha-
nisms and regulation in detail. The structure would help in illuminating the in
vitro and in vivo observations made thus far. Moreover, the nature of the intra/
intermolecular interactions between the TH/SH3 domains needs to be further
addressed, as does the role of the Btk SH3 domain phosphorylation site. As
revealed in this study among others, the interactions of these domains are es-
sential for cell signalling, protein interactions etc. Using molecular and bio-
physical means we have successfully shown the biological significance of these
domain interactions in Btk regulation. Specifically, we showed that the Btk
SH3 domain can interact with the PRR in the N-terminal TH domain. To under-
stand these interactions in the Tec family kinases further experiments are needed
to elucidate the molecular determinants of the various conformational states of
the Tec family kinases. Experiments, which explore the differences in the SH3
domains, the linker region, and the proline rich region would be vital in this
respect.
The diversity of the molecules interacting with Btk and other family members
suggest functions, which are significant and strictly controlled. Several signal
mediators are now known as effectors of Tec family signalling. An understand-
ing of the molecular interactions of the Tec family is essential for addressing
issues related to the basis of signal transduction and diseases arising from muta-
tions in the involved genes. In this regard, the combination of multiple methods
will be vital in attempting to unravel the true complexity of these proteins. One
of the fundamental questions this study answered is, how the N-terminal Btk
(PH, TH, SH3 and SH2) domain interactions are coordinated and regulated to
achieve both spatial and specific interaction.
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